Diabetes develops when your body either stops making insulin, stops responding to it properly, or both. The specific cause depends on which type of diabetes you have, but every form comes down to a problem with insulin, the hormone that moves sugar from your blood into your cells for energy. Type 1 diabetes is driven by the immune system destroying insulin-producing cells. Type 2, which accounts for roughly 90% of cases, develops when cells gradually lose their ability to respond to insulin. Other forms have their own distinct triggers.
Type 1: The Immune System Attacks
Type 1 diabetes is an autoimmune disease. Your immune system’s T cells, which normally fight infections, mistakenly identify the insulin-producing beta cells in your pancreas as threats and destroy them. Immune cells flood into the clusters of beta cells (called islets) in the pancreas, and the attack is surprisingly coordinated. One group of immune cells activates another, which then kills beta cells through direct contact using toxic molecules. Inflammatory signals produced during this process are themselves toxic to beta cells, creating a destructive feedback loop that accelerates the damage.
Nearly all children who develop type 1 before age 5 produce antibodies against their own insulin, which suggests that insulin itself is one of the first targets the immune system locks onto. These autoantibodies, detectable in blood tests, are one of the key ways doctors distinguish type 1 from type 2.
Genetics load the gun, but something in the environment pulls the trigger. The strongest genetic link involves a set of immune-system genes called HLA, which help your body distinguish its own cells from invaders. Certain HLA variants make misidentification of beta cells far more likely. But genes alone don’t cause type 1. Identical twins share the same DNA, yet when one develops type 1, the other only develops it about 30 to 50% of the time. Something else is needed to start the autoimmune process.
Viral Triggers for Type 1
The leading environmental suspects are enteroviruses, particularly the six types of Coxsackie B viruses. The TEDDY study, one of the largest investigations into childhood diabetes triggers, tracked thousands of stool samples from children over time and found that prolonged enterovirus infections (where the same virus appeared in stool samples over several months) were strongly associated with the onset of autoimmunity against beta cells. Brief infections that cleared quickly were not.
One explanation is molecular mimicry. A protein on the Coxsackie B virus closely resembles a protein found on beta cells. When the immune system mounts a response against the virus, it may also begin targeting the lookalike protein on beta cells, setting off the autoimmune destruction. These viruses can also establish persistent, low-level infections in pancreatic tissue, lingering for weeks and potentially keeping the immune system engaged long enough to trigger a lasting autoimmune response. Rotavirus may play a role too: countries that introduced routine rotavirus vaccination saw a drop in type 1 diabetes incidence.
Type 2: Cells Stop Listening to Insulin
Type 2 diabetes starts with insulin resistance, a condition where your muscle, liver, and fat cells gradually become less responsive to insulin’s signals. The root problem in muscle cells involves fat buildup inside the cell. When lipids accumulate in muscle tissue, they activate a chain of molecules that essentially block insulin’s ability to tell the cell to absorb sugar from the blood. The cell’s internal signaling pathway gets jammed at multiple points.
In the liver, a similar process unfolds. Fat accumulation triggers a molecular switch that directly interferes with the insulin receptor on liver cells. When the liver can’t hear insulin’s signal properly, it keeps producing sugar even when blood sugar is already high. This is why fasting blood sugar rises in type 2 diabetes: the liver doesn’t get the message to stop releasing glucose overnight.
For years or even decades before diagnosis, your pancreas compensates by pumping out more and more insulin to overcome this resistance. Blood sugar stays normal during this phase, but the beta cells are under increasing strain. Eventually, the overworked beta cells begin to fail. Chronic high blood sugar itself damages beta cells through oxidative stress and the buildup of harmful byproducts, creating a vicious cycle: resistance leads to high blood sugar, which damages the cells trying to compensate, which leads to even higher blood sugar.
The Role of Body Fat
Excess body fat, particularly fat stored around the organs in your abdomen (visceral fat), is the single biggest modifiable risk factor for type 2 diabetes. Fat tissue isn’t just a passive energy store. It functions as an active organ, releasing dozens of signaling molecules into your bloodstream. Two inflammatory molecules released by fat tissue are central to the problem. These inflammatory signals interfere with insulin signaling in muscle and liver cells through multiple pathways, directly promoting insulin resistance.
What makes visceral fat especially harmful is that it creates a self-reinforcing inflammatory cycle. Fat cells release molecules that trigger inflammation, and those inflammatory signals in turn cause other fat cells to release even more inflammatory molecules. This chronic, low-grade inflammation spreads beyond fat tissue to affect the pancreas, liver, and muscles. It’s one reason why modest weight loss (even 5 to 10% of body weight) can dramatically improve insulin sensitivity: it interrupts this inflammatory loop.
Genetics in Type 2
Type 2 diabetes runs in families, but the genetic picture is very different from type 1. Instead of a few powerful immune genes, type 2 involves many small genetic nudges that each slightly increase your risk. The most significant single gene variant identified is in a gene called TCF7L2. People who carry two copies of the risk variant are at roughly twice the risk of developing type 2 compared to people with no copies. About 10% of people of European descent carry two copies. Notably, this gene variant has zero effect on type 1 risk, confirming these are fundamentally different diseases with different genetic foundations.
Other gene variants affect how the pancreas produces insulin or how cells respond to it, but most have modest effects, increasing risk by about 20%. This means that for the vast majority of people, lifestyle factors like diet, physical activity, and body weight interact with genetic predisposition to determine whether type 2 actually develops.
Gestational Diabetes
During pregnancy, the placenta produces hormones that naturally make the mother’s cells more resistant to insulin. This is actually by design: it keeps more sugar available in the bloodstream for the growing baby. The placenta releases a growth hormone that blocks insulin’s ability to move sugar into cells, and leptin levels rise in a way that promotes inflammation and further reduces insulin sensitivity. Another placental hormone called resistin reduces insulin release from the pancreas while simultaneously making muscle and liver cells less responsive to whatever insulin is produced.
Most pregnant women compensate by producing more insulin. Gestational diabetes develops when the pancreas can’t keep up with the increased demand. Women who already have some degree of insulin resistance before pregnancy (due to excess weight, polycystic ovary syndrome, or genetic factors) are at higher risk because they’re starting from a position where their beta cells are already working harder than usual. Gestational diabetes typically resolves after delivery when the placenta is no longer producing these hormones, but it signals an underlying vulnerability. About half of women with gestational diabetes go on to develop type 2 within 5 to 10 years.
Other Causes of Diabetes
Some forms of diabetes result from direct damage to the pancreas. Chronic pancreatitis gradually replaces healthy pancreatic tissue with scar tissue, cutting off blood supply to the insulin-producing islets and causing progressive beta cell loss. Cystic fibrosis causes a similar pattern: the genetic defect that impairs mucus-clearing throughout the body also leads to inflammation and scarring in the pancreas that eventually compromises insulin production. Digestive enzymes that leak from the damaged pancreas can also directly suppress insulin release from beta cells.
A rare but important category is monogenic diabetes, where a single gene mutation causes the disease. The most common form, called MODY (maturity-onset diabetes of the young), accounts for 1 to 5% of all diabetes cases and is often misdiagnosed as type 1 or type 2. Two gene mutations account for the vast majority of MODY cases: one affects how the liver regulates blood sugar gene expression (responsible for 50 to 70% of cases), and another affects the enzyme that allows beta cells to sense blood sugar levels (30 to 50% of cases). Identifying MODY matters because treatment differs significantly from both type 1 and type 2, and it follows an autosomal dominant inheritance pattern, meaning each child of an affected parent has a 50% chance of inheriting it.
How Diabetes Is Diagnosed
Regardless of the cause, diabetes is diagnosed when blood sugar crosses specific thresholds. The current standards recognize three main tests. A fasting blood sugar of 126 mg/dL or higher (after at least 8 hours without eating) indicates diabetes. An A1C of 6.5% or higher, which reflects your average blood sugar over the past 2 to 3 months, also qualifies. A third option is an oral glucose tolerance test, where blood sugar is measured two hours after drinking a standardized sugar solution: 200 mg/dL or higher confirms the diagnosis.
Unless you have obvious symptoms with very high blood sugar, diagnosis requires two abnormal results, either from different tests taken at the same time or the same test repeated on a different day. Once diabetes is confirmed, distinguishing the type is critical because the causes are different, and so is the treatment. Autoantibody testing can identify type 1, genetic testing can reveal MODY, and clinical history helps identify gestational or pancreatic forms.